Mednet Launches New Healthcare Software
New module designed to provide simple storage of participant consent.
Mednet announced in a company press release its newest software release. Featuring electronic consent capabilities (eConsent) within the iMednet eClinical platform, the organization stated that the new module was designed to provide a simple, cost-effective, and compliant method to collect and store participant consent.
"As the use of electronic consent in clinical trials becomes increasingly necessary across all study types – we are thrilled to add this to our comprehensive toolset," said Rob Robertson, CEO, Mednet, in a company press release. "I am particularly proud of how our team diligently listened to our customers and translated their needs to deliver the optimal combination of functionality, flexibility, and affordability."
Reference: Mednet Launches eConsent Functionality in Latest Release. PR Newswire. October 4, 2023. Accessed October 6, 2023. https://www.prnewswire.com/news-releases/mednet-launches-econsent-functionality-in-latest-release-301947495.html
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
